Changes in bone turnover following gonadotropin-releasing hormone (GnRH) agonist administration and estrogen treatment in cynomolgus monkeys: A short-term model for evaluation of antiresorptive therapy

Bone

Volumn 28, Issue 5, 2001, Pages 532-537

  Stroup, G B ^a   Hoffman, S J ^a   Vasko Moser, J A ^a   Lechowska, B A ^a   Jenkins, E L ^a   Dare, L C ^a   Gowen, M ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antiresorptive; Bone turnover; Estrogen; Gonadotropin releasing hormone (GnRH); Monkey; Primate

Indexed keywords

ESTRADIOL; GONADORELIN AGONIST; LEUPRORELIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE ATROPHY; BONE TURNOVER; CONTROLLED STUDY; ESTROGEN DEFICIENCY; FEMALE; MONKEY; NONHUMAN; OSTEOLYSIS;

AMINO ACIDS; ANIMALS; BONE AND BONES; BONE DENSITY; BONE REMODELING; BONE RESORPTION; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGENS; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MACACA FASCICULARIS; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; RECOVERY OF FUNCTION;

EID: 0035052237     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(01)00421-5     Document Type: Article

References (23)

1. Hormone replacement therapy in postmenopausal women-urinary N-telopeptide of type I collagen monitors therapeutic effect and predicts response of bone mineral density
2. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion
3. Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis; A randomized, placebo-controlled, double-blind study. Lupron Study Group
4. Increases in bone mineral density after discontinuation of daily human parathyroid hormone and gonadotropin-releasing hormone analog administration in women with endometriosis
5. Prevention of estrogen deficiency-related bone loss with human parathyroid hormone-(1-34); A randomized controlled trial
6. The collagen crosslinks pyridinoline and deoxypyridinoline-a review of their biochemistry, physiology, measurement, and clinical applications
7. Effects of add-back therapy on bone mineral density and pyridinium crosslinks in patients with endometriosis treated with gonadotropin-releasing hormone agonists
8. 17 beta-estradiol protects rats from osteopenia associated with administration of the luteinising hormone releasing hormone (LHRH) agonist, buserelin
9. A new way to induce oestrogen-deficiency osteopaenia in the rat; Comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and composition
10. Bone functional changes in intact, ovariectomized, and ovariectomized, hormone-supplemented adult cynomolgus monkeys (Macaca fascicularis) evaluated by serum markers and dynamic histomorphometry
11. Development of osteopenia in ovariectomized cynomolgus monkeys (Macaca fascicularis)
12. Decreased bone mass and strength in ovariectomized cynomolgus monkeys (Macaca fascicularis)
13. Structural histomorphometric analysis of cortical, transitional, and cancellous vertebral bone in intact, ovariectomized, and nandrolone-treated cynomolgus monkeys (Macaca fascicularis)
14. Ovulation inhibition by administration of weekly gonadotropin-releasing hormone antagonist
15. A potential primate model for bone loss resulting from medical oophorectomy or menopause
16. Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration
17. A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomyomata
18. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy
19. Total and regional bone mineral content in women treated with GnRH agonists
20. Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates
21. Analysis of relationships between sex hormone dynamics and bone metabolism and changes in bone mass in surgically induced menopause
22. A risk benefit assessment of drugs used in the treatment of endometriosis
23. Effect of administration and subsequent cessation of buserelin on cancellous bone of female rats